Adtran Inc. (ADTN) Jumps 5.42% on January 21

Equities Staff  |

Adtran Inc. (ADTN) was among the biggest gainers on the Russell 2000 for Thursday January 21 as the stock popped 5.42% to $18.87, representing a gain of $0.97 per share. Some 1.98 million shares traded hands on 12,651 trades, compared with an average daily volume of 470,585 shares out of a total float of 49.56 million. The stock opened at $18.33 and traded with an intraday range of $18.98 to $17.73.

After today's gains, Adtran Inc. reached a market cap of $935.2 million. Adtran Inc. has had a trading range between $24.13 and $13.92 over the last year, and it had a 50-day SMA of $16.65 and a 200-day SMA of $16.18.

The stock has a P/E Ratio of 42.6.

Adtran Inc provides networking and communications equipment. Its solutions enable voice, data, video and Internet communications across a variety of network infrastructures.

Adtran Inc. is based out of Huntsville, AL and has some 2,080 employees. Its CEO is Thomas R. Stanton.

For a complete fundamental analysis analysis of Adtran Inc., check out’s Stock Valuation Analysis report for ADTN. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change










World Economic Forum at Davos 2019 - Frank Ricotta CEO BurstIQ

Matt Bird sits down with Frank Ricotta, CEO BurstIQ, at the World Economic Forum at Davos 2019

Emerging Growth

Q BioMed Inc

Q BioMed Inc is a biomedical acceleration and development company. The company is a biomedical acceleration and development company focused on licensing, acquiring and providing strategic resources to life sciences…